Transcript WHO Essential Drugs Strategy

Access to Essential Medicines
selection, affordability, financing, supply systems
Marthe M Everard
Policy, Access, and Rational Use (PAR)
Medicines Policy and Standards (PSM)
World Health Organization
([email protected])
Access to essential medicines
- framework for coordinated action
1. Rational
3. Sustainable
selection
financing
ACCESS
2. Affordable
prices
4. Reliable
health and
supply
systems
Access to essential medicines
- a framework for coordinated action (1)
1. Rational selection - define what is most needed




develop evidence-based treatment guidelines
define EML based on treatment guidelines
regularly update guidelines based on best evidence
use for supply, reimbursement, training
2. Affordable prices - promote competition & reduce costs





3
price information
generics policies
reduce duties, taxes, markups
differential pricing of new essential medicines
apply WTO/TRIPS safeguards as appropriate
Access to essential medicines
- a framework for coordinated action (2)
3. Sustainable financing - increase sustainable funding




increase public funding
expand health insurance
better use of out-of-pocket spending
targeted external funding - grants, loans, donations
4. Reliable health & supply systems - ensure quality & availability




4
integrate medicines in health sector development
create efficient public-private-NGO mix
assure medicine quality
promote rational use of medicines
Disease patterns should guide medicine selection,
supply management, use, training/supervision
Medicine
development
Essential
Medicines list
Disease
patterns
Choice of medicine
and non-drug
treatments
Training,
supervision of
health providers
Financing, prices, supply
management of medicines
Patient
Information, use
of medicines
5
Clinical guidelines,
formularies
WHO Essential Medicines Library
- Various information sources together
WHO clusters
WHO/PSM/PAR
BNF
Clinical guidelines
Summary of clinical guidelines
Drug Info:
- WHO Model
Formulary
WHO/ExCee; Cochrane
Reference info:
- Reasons for inclusion
- Systematic reviews
- Key references
MSH-UNICEF-MSF
Price/Cost info:
- per unit
- per treatment
- per month
- per case prevented
6
WHO
Model List
WHO/PSM/QSM
WCCs
Oslo/Uppsala
Statistics Info:
- ATC
- DDD
Quality info:
- Basic quality tests
- Int. Pharmacopoeia
- Reference standards
Response
- One strategy across WHO
malaria
other priority
health problems
tuberculosis
HIV/AIDS
childhood
illness
Four strategic objectives
1. Access - selection, financing, pricing, reliable health and supply systems
2. Quality and safety - standards, effective drug regulation, information
3. Rational use - health professionals and consumers, public and private
4. National drug policy - framework for collective action
7